ATLANTA -- For people with stable coronary artery disease and refractory angina, a coronary sinus reducer (CSR) implant showed a symptom alleviation benefit in the small placebo-controlled ...

The coronary sinus is a collection of smaller veins that merge together to form the sinus (or large vessel), which is located along the heart’s posterior (rear) surface between the left ventricle and ...

A recent state-of-the-art review overlooks a “safe and effective” therapy for patients with stable angina and no good treatment options, according to several cardiologists. The coronary sinus reducer ...

Please provide your email address to receive an email when new articles are posted on . A coronary sinus reducer reduced the frequency of angina events for patients with significant CAD. However, the ...

A device that narrows the coronary sinus can reduce angina symptoms and improve quality of life in patients with refractory angina who are not candidates for revascularization, according to phase II ...

BOSTON, MA — In a randomized trial of 104 patients with disabling angina, those who had the Reducer (Norvasc, Richmond, BC) implanted into their coronary sinus had significantly reduced symptoms and ...

ATLANTA, GA — Despite failing to increase perfusion as hypothesized, a coronary sinus reducer (CSR) in a sham-controlled randomized trial meaningfully reduced angina and improved quality of life in ...

The success rate of cardiac resynchronization therapy (CRT) implantation, according to a recent study, could be improved by the use of an endocardial visualization catheter (EVC), which allows direct, ...

Background. A 52-year-old man presented with central chest pain, which he had experienced for 8 h. He had no other associated symptoms and no prior history of cardiovascular disease. Investigations.